- Q1 2024 Emergent BioSolutions Inc Earnings Call TranscriptMay 01, 2024Earnings
- Q4 2023 Emergent BioSolutions Inc Earnings Call TranscriptMar 06, 2024€3.04 (-3.55%)Earnings
- Emergent BioSolutions Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 Emergent BioSolutions Inc Earnings Call TranscriptNov 08, 2023€2.22 (+2.58%)Earnings
- Q2 2023 Emergent BioSolutions Inc Earnings Call TranscriptAug 08, 2023€6.66 (+0.60%)Earnings
- Q1 2023 Emergent BioSolutions Inc Earnings Call TranscriptMay 09, 2023€8.26 (+2.48%)Earnings
- Q4 2022 Emergent BioSolutions Inc Earnings Call TranscriptFeb 27, 2023€12.94 (-3.53%)Earnings
- Q3 2022 Emergent BioSolutions Inc Earnings Call TranscriptNov 08, 2022€20.18 (+0.96%)Earnings
- Q2 2022 Emergent BioSolutions Inc Earnings Call TranscriptAug 01, 2022€33.67 (-4.70%)Earnings
- Emergent BioSolutions Inc at Goldman Sachs Leveraged Finance and Credit Conference TranscriptMay 12, 2022
- Emergent BioSolutions Inc at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Q1 2022 Emergent BioSolutions Inc Earnings Call TranscriptApr 28, 2022€34.68 (-0.43%)Earnings
- Emergent BioSolutions Inc at KeyBanc Capital Markets Life Sciences & MedTech Forum (Virtual) TranscriptMar 22, 2022
- Q4 2021 Emergent BioSolutions Inc Earnings Call TranscriptFeb 24, 2022€36.49 (-3.85%)Earnings
- Emergent BioSolutions Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Q3 2021 Emergent BioSolutions Inc Earnings Call TranscriptNov 04, 2021€45.25 (+3.38%)Earnings
- Emergent BioSolutions Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- Q2 2021 Emergent BioSolutions Inc Earnings Call TranscriptJul 29, 2021€54.82 (+4.30%)Earnings
- Emergent BioSolutions Inc Annual Shareholders Meeting TranscriptMay 20, 2021
- Q1 2021 Emergent BioSolutions Inc Earnings Call TranscriptApr 29, 2021€50.48 (-4.07%)Earnings
- Emergent BioSolutions Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 01, 2021
- Q4 2020 Emergent BioSolutions Inc Earnings Call TranscriptFeb 18, 2021€101Earnings
- Emergent BioSolutions Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Q3 2020 Emergent BioSolutions Inc Earnings Call TranscriptNov 05, 2020€84 (+5.66%)Earnings
- Emergent BioSolutions Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2020
- Q2 2020 Emergent BioSolutions Inc Earnings Call TranscriptJul 30, 2020€80 (+2.56%)Earnings
- Emergent BioSolutions Inc Annual Shareholders Meeting TranscriptMay 21, 2020
- Emergent BioSolutions Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 12, 2020
- Q1 2020 Emergent BioSolutions Inc Earnings Call TranscriptApr 30, 2020€68.5 (+0.74%)Earnings
- Q4 2019 Emergent BioSolutions Inc Earnings Call TranscriptFeb 20, 2020€59.5 (+0.85%)Earnings
- Emergent BioSolutions Inc at JPMorgan Healthcare Conference TranscriptJan 14, 2020
- Emergent BioSolutions Inc Analyst and Investor Day TranscriptNov 21, 2019
- Q3 2019 Emergent BioSolutions Inc Earnings Call TranscriptNov 06, 2019€52 (+2.97%)Earnings
- Q2 2019 Emergent BioSolutions Inc Earnings Call TranscriptAug 01, 2019€39.65 (-0.92%)Earnings
- Emergent BioSolutions Inc Annual Shareholders Meeting TranscriptMay 23, 2019
- Q1 2019 Emergent BioSolutions Inc Earnings Call TranscriptMay 02, 2019€46.51 (-2.15%)Earnings
- Q4 2018 Emergent BioSolutions Inc Earnings Call TranscriptFeb 21, 2019€57.45 (-0.95%)Earnings
Emergent BioSolutions Inc at KeyBanc Capital Markets Life Sciences & MedTech Forum (Virtual) Transcript
Hello and welcome to KeyBanc's 2022 healthcare conference. My name is Harrison Schrage; I am an equity research associate on Paul Knight's life sciences team here in New York. Here, we will be discussing Emergent BioSolutions with COO, Adam Havey; and CFO, Rich Lindahl. (Conference Instructions)
Now I'll pass it off to Adam and Rich for an overview of Emergent.
Thank you, Harrison, and thank you, everybody, for participating today. I'm just going to provide a few minutes of overview just to introduce the company to you, in case you're not familiar. It starts by the fact that we are a company that develops, manufactures, and delivers protections against public health threats through a pipeline of innovative vaccines and therapeutics. We've got a growth strategy from 2020 through 2024 that we are executing against, highlighted by five key elements.
We are executing against our core business. We're looking to grow through
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)